One could conjecture the possibility of an interaction of Apaf-1 with lipid raft-associated proteins, such as the receptor tyrosine kinase, c-Met, which is used as a prognostic marker for DLBCL [36]. This evidence concerns the gene APAF1 and diffuse large B-cell lymphoma.